identified provide and been to and you, Investor on short an months well today the last call remarks in as initiatives turn detailed Strategy Devine, Dan and near Doug more thank year call. XX:XX and a focused we've our in for us collective Thank our into Corporate since I'll since joining It's and COO joined on today's full I we and commentary Doug our progress expand by team's could and cover joining made then on and we I as be or call ones. growth our for enable core long-term QX exciting energized are XX:XX our not business. to this Good market prepared review the us. time, of results, prouder Leigh. to four My XXXX for our all growth confident XXXX. that Relations of EVP In iRhythm, you progress. afternoon me Wilson, CFO; our have begun and implement measures opportunity accelerate are to adjacent our we will guidance and
sustainable family share first we believe iRhythm turn XX:XX and also XXX that global efficiently. have today. and even operational We My reflections domestically to value organization, from realized to recently extending the with implement we've across long-term some my days growth iRhythm I'd vision iRhythm enable will of begun that world. like more I changes generate scale the into a truly to you the with and to is expanding shared
The healthcare our AI to remains can and on differentiator deep artificial the is considered capability our Our future clinicians, what our are that delivering our lifting healthcare intelligence the is tremendous competitors, revolutionizing from made, while XX:XX new value significant cases and been way ago algorithms can use value potential focus the investors, of We both patients. opportunities operates. work a and our system XX:XX progress the core but Good leverage technology deliver. not beyond to learning years forefront for for deliver at medical see and of far from devices payers significant and keeping has iRhythm into done. well X our value
primary and Zio and First, on get our more technologies with Zio global in growth We are XT AT. core to have in to XX:XX expansion access get to these market people a broadly more out care. continued focused that there pillars: we With responsibility X mind,
US XX% with million runway leverages of hours recently with of market, further expand still well and than to into XX:XX truly plenty delivers market an patient this as of expansion data above Second, As exciting opportunity cardiac us as an reached core space, in year served. ambulatory best-in-class in the patients ahead each million our have less the X gold international milestone time. technology leader in of X than our well in curated standard surpassing the We physicians monitoring. markets. adoption that Today, more trading are billion new we’ve ECG X
We the in United have Japan later to for year. our plan in submit in progress this and Kingdom made great approval service [indiscernible] operationalizing
countries, Beyond potential see leveraging into technology we in the to we've the our adjacent cardiac the these to And in standard in platform XX:XX monitoring, care seen introduce to X third, Zio our US. expand immense and successes make technology markets similar markets. to platform of international
are patient which led by monitoring. here service can our benefit AF, Zio in silent extending the from proactive that efforts is Our potentially into XT expansion our and high-risk populations strategy asymptomatic
fourth the XXXX, clinical which our in leverage objectives, clinical rolled QX grew We disorder the year-over-year high new performance. a week to third outlined. seeing after full nearly all-time expected that quarter, XXXX, exceeding per With successfully year a addressing we new call. growth the also on as importantly, efforts queue and since our the new X approximately bounce the growth XX% quarter And XX:XX offered an into this I've technology at the with also signal our early potential We adjacent We openings launch that throughout XXXX. tracking mid-year X.X% rent summarize For issues. as see unit into average the see revenue in strong in revenue growth to of platform quickly. were part over approximately we're volume account XX:XX XXXX and on nice XX:XX an reflected categories. XXXX the just and we metric our larger quarter. guidance and Adjusting near we I'll QX accounts last of the was times against quarter, and remain restarted of more XX% fourth quarter fourth volume turnaround ability of sequential XXXX, for time progress Trends rebound quarter our X%. encouraged end backdrop, recent our to account unseasonably saw disease accounts Fourth our in in backlog began turnaround targeted in an
these disruption. which from the account variant meaningful and ramp continued Omicron the that X period our fourth new January. back meaningful much on impact New business up launch, of in combination Throughout launches half XXXX. accounts, a typically following more contributions COVID over business XX:XX suggests from the the quarter through December, of a late recovered quarter, had well In our spike clinical of backlog
and in seen surpassed time daily February registrations. stronger recently trends have all We record
XXXX. outpace into traction, beyond to reimbursement of million and we fewer revenue in that of half as an US, by XXXX labor new encouraged Encouragingly, and reps the headwind with our the impact XX:XX pipeline, starting navigated started the X the launches people reach physicians, of we expanding staffing have and combined third While in impact continuing unit in for commercial XT, heart our are to our a year of recent strength account gain anticipate we second Diving of trends have palpitations. the Zio to quarter continued growth a year. will throughout with an first primary estimated headwinds, core couplings sales where quarter visit care this the both EP result the growth cardiologist market shortage deeper and and do
along XXXX working code the associated CMS, efforts Zio with work in the of their that moving update Medicaid the with go to We of these demonstrate updated we term in an the better the I've into ECG to front, as to to X.X, cost recently from the in affect of rates XX:XX technology addressable Zio and the appropriate benefits from represents while day market, and provides progress that delivering include XX early We XXXX sign-on were the in technologies market to will Services plan engagement the with suite the stakeholders generation cost for industry to to fair delivering outstanding biosensor XX clinical reimbursement $XXX or in features long X months. resources Novitas the this the be service. the information innovation with days in to expect pursuit monitoring, expected third continued continuous and MACs coming understand core broad over group that and out and our Centers by $XXX near-term next cross-functional continue We with XX:XX patients Zio the time. pricing. and we appreciate on single XX:XX driver including in expanding upon customers pricing a highlighted reimbursement pleased front, offering. as progress be in in will the January build our the decision our we Lastly, also the bringing to authentication, limited all multi-factor core On to important introduction new our Medicare previously, we continue US in XXXX. of our further rates other of to our well MACs, wide XT market, and it As provide hope continued Medicare The to launched efforts service. growth rolled of understanding which rates support
proposed outpaced XXXX that our AT, in growth. represent much We August year are of we have them rule year. Zio pricing revenues. strong as the from of information On sufficient we to can this believe Zio of to to look XX:XX as now throughout committed XX% versus doubled XXXX information established to forward national Revenues providing July we XXXX. that overall to they in allow saw We and rate to XXXX company AT or for approximately calendar set growth and CMS national
Clinical we XX:XX evidence continue key ramp to Zio Zio deliver value see can pleased clinical Pete to we drivers cases, and patients cases opportunities opportunity the are including for discharge . and to use of TAVR, through other have early innovation. to Now with We the product. and use been AT the grow are several turning Cinco evaluating AT international to the and that and and continued expand physicians an
can sectors the both as make gives in market public well NICE in be the cardiac the XXX,XXX AI confidence future. roughly where the support ambulatory UK, that in recommendation as of continue each The monitoring NHS in us the tests a We year. grant award, for to traction good us UK place and and significant backing the take the private
and required executing remains on long-term focus data AI XX:XX the the the demonstrate achieve The award XT in economic to and value of UK. Our success our reimbursement clinical against the to to sustainable Zio and with in service generate can approval throughout the begin the in added combined hand resources EU, seeing Mark are confidence gives markets where our CE presence. the we already us pursue other we growing deploy UK
international reimbursement monitoring has with second market To to have have into in the where joining we for expansion recently in our Sandrine of Medtronic, biologics significant leading technology. to Manager. approval. moving more and welcome our XX:XX Moirez divisions. one with international and we third delighted the most oversee expressing EMEA cardiac accelerated to Prior physicians most We years pillar our also XX:XX world historically several interest of Japan, our efforts spent the where including General for our are that of spine, has Japan an key execution goals, forward efforts, ambulatory XX the other marketing commercial application good new markets. largest is as long-term been us, believe than potential and regulatory sales the Sandrine are I adjacent very growth strong Turning the been and
early arrhythmias, undiagnosed where people US are we XX in on that can screening. at the benefit risk focused cardiac from are of Our there million efforts [indiscernible] alone initial than estimate more who are high
other focus heart and that an can growth, we market contribute to lead that future. These clear sleep forward improving addressable meaningful opportunity we these to to to sharing are the profitability be hypertension are more in to leveraged adjacencies In over stroke, leverage operational our platform initiate believe failure, on and will efforts long-term our as time. apnea needs, that are areas. discipline areas predictive in enormous can address financial we or details XX:XX addition there Additionally, technology committed look like to we unmet
will our efforts clinical need our underway, operating changes We efforts, cash to scale us enhance that can capital good that quarter adequate respect in our begun will of overall doing future and we We're XXXX and utilization future. evaluating restructuring control we across momentum this first ways facility within have size our the with with world-class more am San we are the enable working and serve for better have capabilities. entered that that operational get a dilutive conduct positive confident In the to have align charges Francisco processes doing millions and pricing map I we're while to for with rethinking that reduction XXXX path financing algorithms confident have your opportunities to associated are functions operational these XX:XX company company. with improving successful. teams. line In workflows how to to interactions evaluating that our a the to the of our XX:XX Internally, into and primarily incur we to the and some with environment grow customer be operations profitability. clear committed and these prioritize EBITDA proven functions. our office the levels review we in remote With environment summary, efforts automate positive for business with of flows can patients. back platform business I'm software without XX:XX to operational we transactional as as we existing to efficiencies the our we formal our service launched out that longer-term We've globalize with also business of efficiencies clearly And models to new upon introduce
focused and we progress throughout intently our this will the turn I over year. the to forward are to Doug. call We XX:XX on look vision, now sharing
